Recombinant Glycine max CDC48 Protein ，His & SUMO

CDC48, also known as VCP (valosin-containing protein), is an essential member of the AAA+ ATPase family and plays a crucial role in various cellular processes, including protein degradation, membrane fusion, and cell cycle regulation. A growing body of research has highlighted its involvement in the ubiquitin-proteasome system, where it mediates the extraction of ubiquitinated substrates from protein complexes, facilitating their subsequent degradation. Dysregulation of CDC48 has been implicated in several diseases, including cancer, neurodegenerative disorders, and protein aggregation diseases, thus making it a vital target for therapeutic intervention. Understanding the structural and mechanistic nuances of CDC48 is key to elucidating its role in these diseases. Recent studies have focused on the reconstitution of CDC48’s functional activities in vitro, which has allowed for greater insights into its ATPase activity and substrate interactions. By employing various biochemical and biophysical techniques, researchers aim to dissect the protein's conformational changes during activation and substrate processing. Furthermore, exploring CDC48's interaction partners provides a broader understanding of its cellular network. Given its pivotal role in maintaining proteostasis and cellular homeostasis, elucidating the precise mechanisms by which CDC48 operates is essential for developing targeted therapies that could ameliorate the pathological consequences of its dysfunction. Overall, the study of CDC48 is crucial not only for basic biological understanding but also for uncovering novel therapeutic avenues for diseases associated with its malfunction.